Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 5, Issue 3

Abstract

Background: Heart failure is a complex clinical syndrome, impairing the ability of the cardiac ventricles to fill with or eject blood. Drug therapy for Chronic Heart Failure (CHF) is aimed at providing symptomatic relief and has to be continued indefinitely. Currently Angiotensin Converting Enzyme Inhibitor (ACEI), beta blocker and diuretic form the basis of treatment for CHF. These drugs can cause a wide array of electrolyte disturbances which frequently result in potentially dangerous complications. Early identification of these electrolyte disturbances and knowledge of the pathophysiological mechanisms underlying them will help in the effective management of these patients, when complex combinations of drugs are used. Objectives: 1.To estimate the serum sodium and potassium levels in ‘stable’ Chronic Heart Failure (CHF) patients on treatment. 2. To study the impact of Angiotensin Converting Enzyme inhibitors (ACEI), beta blockers and spironolactone with or without furosemide on serum sodium and potassium levels in stable CHF patients receiving the above drugs. Materials and Methods: A cross-sectional study was conducted on 120 stable chronic heart failure patients. In this, 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers, spironolactone and furosemide, while the other 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers and spironolactone regimen. Serum creatinine, sodium and potassium levels were analyzed in both the group. Conclusion: Majority of the drugs used in the treatment of CHF cause electrolyte disturbances. Hyponatremia in patients receiving all the four drugs and hyperkalemia in patients receiving only three drugs, was observed in our study.

Authors and Affiliations

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri

Keywords

Related Articles

Study of oxidative stress and antioxidants among pre eclamptic pregnant women

Aim and Objectives: To study the significance of oxidative stress and antioxidants levels in pre eclampsia patients in comparison with normotensive pregnant women. Materials and Methods: Cross sectional study includes 30...

Lipid profile patterns in university students

Background: Early detection of lipid imbalance should begin in adolescence in order to focus on long-term prevention of atherosclerosis by controlling the risk factors. Aim: The present study was, designed to study lipid...

Blood lactate levels and its association with survival outcome in polytrauma patients

Background: Lactate as a marker for tissue hypoperfusion is an established biomarker for morbidity and mortality in patients with sepsis and trauma, but has limited clinical application. Aim of this study is was signific...

Leptin, Insulin resistance and Dyslipidemia in Acanthosis Nigricans

Background: Leptin is a adipocytokine hormone, with 167 amino acids. It acts via hypothalamic neuronal pathway, signalling satiety centre and controlling body weight. Acanthosis nigricans is associated with Leptin, obesi...

Comparison of serum leptin concentration and electrolytes in pre-eclampsia and normal pregnancy

Background: Preeclampsia is one of the leading causes of maternal as well as perinatal morbidity and mortality. Studies have shown that leptin has also been implicated in the pathogenesis of many of the maternal features...

Download PDF file
  • EP ID EP362221
  • DOI -
  • Views 154
  • Downloads 0

How To Cite

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri (2018). Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens. Medpulse International Journal of Biochemistry, 5(3), 116-119. https://europub.co.uk./articles/-A-362221